Company Filing History:
Years Active: 2014-2017
Title: Albrecht Gruhler: Innovator in Inflammatory Disease Treatment
Introduction
Albrecht Gruhler is a notable inventor based in Frederikssund, Denmark. He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory diseases. With a total of 3 patents to his name, Gruhler's work is recognized for its potential impact on healthcare.
Latest Patents
Gruhler's latest patents focus on antagonistic DR3 ligands, which are crucial for the treatment of inflammatory diseases. The first patent details the use of these ligands in therapeutic applications, emphasizing their role in managing inflammatory conditions. The second patent reiterates the importance of antagonistic DR3 ligands, further highlighting their utility in treating such diseases.
Career Highlights
Albrecht Gruhler is currently associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk has allowed him to collaborate with other experts in the field, enhancing the development of innovative treatments.
Collaborations
Some of Gruhler's notable coworkers include Mette Dahl Andersen and Peder Lisby Noerby. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical industry.
Conclusion
Albrecht Gruhler's innovative work in the field of inflammatory disease treatment showcases his dedication to improving healthcare outcomes. His patents on antagonistic DR3 ligands reflect a promising avenue for future medical advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.